Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thaller AL"'
Autor:
Thaller AL; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Jönsson F; Institut Pasteur, Antibodies in Therapy and Pathology Unit, Université Paris Cité, Inserm U1222, Paris, France., Fiquet O; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Marie S; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Doisne JM; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Girelli-Zubani G; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Eri T; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Fernandes P; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Tatirovsky E; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Langa-Vives F; Institut Pasteur, Mouse Genetics Engineering Platform, Université Paris Cité, Paris, France., Bruhns P; Institut Pasteur, Antibodies in Therapy and Pathology Unit, Université Paris Cité, Inserm U1222, Paris, France., Strick-Marchand H; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France., Di Santo JP; Institut Pasteur, Innate Immunity Unit, Université Paris Cité, Inserm U1223, Paris, France.
Publikováno v:
European journal of immunology [Eur J Immunol] 2023 Dec; Vol. 53 (12), pp. e2350454. Date of Electronic Publication: 2023 Aug 31.
Autor:
Thaler FS; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Thaller AL; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Biljecki M; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Schuh E; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Winklmeier S; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Mahler CF; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Gerhards R; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Völk S; Department of Neurology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Schnorfeil F; Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany., Hohlfeld R; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Kümpfel T; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany., Meinl E; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, Munich, Germany.
Publikováno v:
Annals of neurology [Ann Neurol] 2019 Mar; Vol. 85 (3), pp. 448-454. Date of Electronic Publication: 2019 Jan 28.
Autor:
Schmid I; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Bonnington L; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Gerl M; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Bomans K; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Thaller AL; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Wagner K; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Schlothauer T; Pharma Research and Early Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Falkenstein R; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Zimmermann B; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Kopitz J; Department of Applied Tumor Biology, Institute of Pathology, Medical School of the Ruprecht-Karls-University, Im Neuenheimer Feld 224, Heidelberg, 69120, Germany., Hasmann M; Pharma Research and Early Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Bauss F; Pharma Research and Early Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Haberger M; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Reusch D; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany., Bulau P; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany. patrick.bulau@roche.com.
Publikováno v:
Communications biology [Commun Biol] 2018 Apr 05; Vol. 1, pp. 28. Date of Electronic Publication: 2018 Apr 05 (Print Publication: 2018).